A carregar...

A Critical Evaluation of Neuroprotective and Neurodegenerative MicroRNAs in Alzheimer’s Disease

Currently, 5.4 million Americans suffer from AD, and these numbers are expected to increase up to 16 million by 2050. Despite tremendous research efforts, we still do not have drugs or agents that can delay, or prevent AD and its progression, and we still do not have early detectable biomarkers for...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biochem Biophys Res Commun
Main Authors: Reddy, P. Hemachandra, Tonk, Sahil, Kumar, Subodh, Vijayan, Murali, Kandimalla, Ramesh, Kuruva, Chandra Sekhar, Reddy, Arubala P.
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5343756/
https://ncbi.nlm.nih.gov/pubmed/27524239
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbrc.2016.08.067
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!